Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
about
Nanoengineering approaches to the design of artificial antigen-presenting cellsMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionOptimized staining and proliferation modeling methods for cell division monitoring using cell tracking dyesAn Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T CellsKiller artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppressionShaping the future of nanomedicine: anisotropy in polymeric nanoparticle designConnecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells.Biomimetic delivery with micro- and nanoparticlesA biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Surface engineering for lymphocyte programming.Fas mediates cardiac allograft acceptance in mice with impaired T-cell-intrinsic NF-kappaB signaling.Antigen-specific killer polylactic-co-glycolic acid (PLGA) microspheres can prolong alloskin graft survival in a murine model.Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.
P2860
Q27023634-BD670C19-EBEF-4D61-9651-E71D571421E5Q28080720-773F1995-C6EC-4162-9F0E-DF8176A677D8Q28681906-EAF44939-A72E-4B8A-8474-0CB26A18CBC3Q33780582-16FF92B7-1EF8-41C3-B15D-660FC5531991Q34139182-DC5EE145-2A5D-4095-BAFE-5D55FB2C79C4Q34175958-0F3F0A6E-7A2E-4AEE-9EB3-312640D3D78DQ36279715-D8BB8342-DF3E-45D7-A351-686E13C982A7Q36383130-CA6DA195-B717-42FC-A8C2-056F41798D81Q36454872-C110BE8C-D47E-447B-A9A8-F10D28E9AEE9Q36768786-08E2A266-2601-4EC5-A455-DBA59C4C3DDAQ37022139-2A7FF9B0-41AB-4423-8751-7643E273C98AQ37177987-3536136F-8560-4D21-9BA8-EC2A53FCFF30Q37678250-3B3CBF3A-DF2F-4BB2-8C55-0295A09474B9Q38645059-F7D03D96-E7AD-41B9-AD29-13F6DA7FBA7FQ40044791-7B88D95B-093D-409A-A1F7-FA9FC253FE18Q40214162-7B0DB56F-1F90-4A86-AEC2-C1313A01D5FDQ40407883-7BFF18F0-13E3-4B39-90F0-0C2FA94CF8F1Q40975411-1F2D2AEE-FBC6-4B48-AE95-6F530855A1C0Q42752862-FF11DDF5-F2C1-497E-8AEC-CEEFF1026823Q50526246-E4573253-69C5-4D3F-B95C-0BE8ED28A9F0Q52366029-1795F063-7871-4407-9BEA-13C1B176D1FA
P2860
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@ast
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@en
type
label
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@ast
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@en
prefLabel
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@ast
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@en
P2093
P2860
P1433
P1476
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
@en
P2093
Alessia Zoso
Andreas Mackensen
Christian Schütz
Dagmar Halbritter
Jonathan P Schneck
Martin Fleck
Mathias Oelke
P2860
P304
P356
10.1182/BLOOD-2007-09-113522
P407
P577
2007-12-20T00:00:00Z